Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin ototoxicity in patients with normal renal function.

J A Mellor, J Kingdom, M Cafferkey

    British Journal of Audiology
    |August 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Optimal umbilical artery Doppler chart for predicting placenta-mediated fetal growth restriction.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
    Same author

    Clinical outcomes following implementation of diagnostic testing for pre-eclampsia within a UK tertiary hospital setting using angiogenic biomarkers.

    Pregnancy hypertension·2025
    Same author

    Safety and feasibility pilot study of continuous low-dose maternal supplemental oxygen in fetal single ventricle heart disease.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
    Same author

    Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

    Physical review letters·2024
    Same author

    Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.

    Annals of oncology : official journal of the European Society for Medical Oncology·2023
    Same author

    Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

    Physical review letters·2022
    Same journal

    Effects of slow- and fast-acting compression on the detection of gaps in narrow bands of noise.

    British journal of audiology·2002
    Same journal

    Measurement of first- and second-order modulation detection thresholds in listeners with cochlear hearing loss.

    British journal of audiology·2002
    Same journal

    Comparison of three procedures for initial fitting of compression hearing aids. I. Experienced users, fitted bilaterally.

    British journal of audiology·2002
    Same journal

    Assessing service quality in paediatric audiology and early deaf education.

    British journal of audiology·2002
    Same journal

    Comparison of the electroacoustic characteristics of five hearing aids.

    British journal of audiology·2002
    Same journal

    Use of the 'real-ear to dial difference' to derive real-ear SPL from hearing level obtained with insert earphones.

    British journal of audiology·2002
    See all related articles

    Vancomycin can cause hearing loss (ototoxicity) even in patients with normal kidney function. This rare side effect challenges the belief that vancomycin is always safe at standard doses.

    Area of Science:

    • Nephrology
    • Ototoxicology
    • Pharmacology

    Background:

    • Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections.
    • Renal function is a primary factor in vancomycin dosing and toxicity monitoring.
    • Established guidelines aim to maintain therapeutic vancomycin levels while minimizing nephrotoxicity and ototoxicity.

    Observation:

    • Three patients with preserved renal function experienced documented ototoxicity.
    • Ototoxicity manifested during standard vancomycin treatment regimens.
    • These cases highlight a potential disconnect between perceived safety and clinical outcomes.

    Findings:

    • Ototoxicity occurred in patients with normal renal function, suggesting non-renal mechanisms.
    • The incidence of vancomycin-induced ototoxicity may be underestimated in specific patient populations.

    Related Experiment Videos

  • This challenges the assumption that normal renal function guarantees vancomycin safety.

    • Implications:

    • Clinical practice may need to reconsider "safe" vancomycin dosing thresholds.
    • Enhanced monitoring for ototoxicity is warranted, irrespective of renal status.
    • Further research into vancomycin ototoxicity mechanisms is crucial for patient safety.